About the Webinar
Cancer stem cells are also known to be responsible for tumor development, metastasis, and degeneration after conventional therapies. Emergent therapeutic strategies in cancer have been focusing to stimulate an immune response against tumors by using mAbs and since the inception of mAbs as cancer fighters, researchers are identifying and characterizing the stem cells of different tumor types.
Since mAbs should be able to facilitate earlier diagnosis by targeting specific antigens transformed in cancer stem cells through molecular imaging which enables efficient destruction of tumor initiating cells, and they improve clinical outcome for patients undergoing treatment.
To gain more knowledge on this, please join in with Prof. Jaroslav Michalek MD Ph.D., Cellthera Clinic, Brno, Czech Republic
- Medical Practitioners running their own clinical practice in Clinics/Hospitals
- Clinic/Hospital owners/Hospital administrators
Jaroslav Michalek Cellthera Clinic, Brno, Czech Republic
20 years experience in regenerative medicine, stem cell therapy, anti-cancer immunotherapy. Board-certified in Immunology, Oncology, Pediatrics. Prof. He has 16 years of experience in regenerative medicine and cell therapy. He is a president of the International Consortium for Cell Therapy and Immun
Just in time medical learning platform